Evidence mapPaperPMID 41803705Full record

ArticleBMC microbiology2026

A longitudinal evaluation of localised chronic Pseudomonas aeruginosa infection in cystic fibrosis rat models.

Nicole Reyne, Bernadette Boog, Patricia Cmielewski, Alexandra McCarron, Ronan Smith, Nathan Rout-Pitt, Nina Eikelis, Kris Nilsen, John Finnie, Jennie Louise and 2 more

Abstract read
In one paragraph

Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nicole ReyneRobinson Research Institute, Adelaide University, Adelaide, South Australia, Australia. nikki.reyne@adelaide.edu.au.
Bernadette BoogRobinson Research Institute, Adelaide University, Adelaide, South Australia, Australia.
Patricia CmielewskiRobinson Research Institute, Adelaide University, Adelaide, South Australia, Australia.
Alexandra McCarronRobinson Research Institute, Adelaide University, Adelaide, South Australia, Australia.
Ronan SmithRobinson Research Institute, Adelaide University, Adelaide, South Australia, Australia.
Nathan Rout-PittRobinson Research Institute, Adelaide University, Adelaide, South Australia, Australia.
Nina Eikelis4DMedical, Melbourne, Victoria, Australia.
Kris Nilsen4DMedical, Melbourne, Victoria, Australia.
John FinnieSchool of Medicine, College of Health, Adelaide University, Adelaide, South Australia, Australia.
Jennie LouiseBiostatistics Unit, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
David ParsonsRobinson Research Institute, Adelaide University, Adelaide, South Australia, Australia.
Martin DonnelleyRobinson Research Institute, Adelaide University, Adelaide, South Australia, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrent bacterial infections with Pseudomonas aeruginosa result in chronic airway inflammation, lung damage and eventual respiratory failure, and are the major cause of morbidity and mortality in people with cystic fibrosis (CF). Animal models are essential for understanding disease progression and assessing potential treatments in the presence of infection. Previously reported P. aeruginosa lung infection rodent models for CF research have weaknesses that include being acute rather than chronic infections, high levels of associated mortality, use laboratory strains of P. aeruginosa, or do not utilise CF rodents. The aim of this study was to create a localised single-lung P. aeruginosa infection in wildtype and two CF rat models, by using a miniature bronchoscope to deliver bacteria embedded in agar beads generated from a clinical CF bacterial isolate. Cohorts of animals were assessed at days 7, 14, 21 and 63. The number of colony forming units were measured, along with bronchoalveolar lavage, flexiVent mechanics, X-ray Velocimetry (XV) ventilation analysis, and histopathology. The resulting infection was well tolerated by all animals of all genotypes with no mortality associated with the procedure or infection. The right-lung exhibited localised acute bronchopneumonia and lymphocytic vasculitis early, progressing to chronic interstitial pneumonia with fibrosis and emphysema. Bacteria persisted for 9 weeks (63 days) in all genotypes, with lung mechanics changes observed by day 63 of the infection. The precise delivery of bacterial laden beads using a miniature bronchoscope generated a controlled and reproducible infection that persisted for up to nine weeks, with minimal impact on animal health.

Indexed as

Cystic FibrosisDisease Models, AnimalPersistent InfectionPseudomonas aeruginosaPseudomonas InfectionsAnimalsLongitudinal StudiesLungMaleRatsAnimal modelCystic fibrosisLung infectionPseudomonas aeruginosa

Identifiers

PMID41803705
PMCPMC13085380

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.